Insulet Corporation

NASDAQ:PODD

Medical - Devices

Healthcare
$139.98 -2.82%

-$4.17 today

Market cap
$9.71B
Beta
1.13
P/E (TTM)
33.2
EPS (TTM)
$4.33
52W Low $140.63High $354.88

Volume 2.09M

Average 1.32M

PODD Net Income

Bottom-line profit, the starting point for calculating cash from operations.

Insulet CorporationNASDAQ: PODD

Net Income · Q2 FY2026 · quarter ended Jun 2026

Net income growth accelerates

Q2 FY2026 net income of $95M rose 322.2% year over year, ahead of the +59.0% change in trailing-twelve-month net income. Sequentially, it rose 4.3% from the prior quarter. Over 3 fiscal years it compounded at +277.3% a year.

Context

  • Net income amounted to 9.1% of revenue in FY2025, down 11.1 pp from a year earlier.
  • Net income increased in 2 of the last 3 fiscal years.

What to watch

Whether net income reaches the consensus estimate from 19 analysts of $489.48M (+98.1%) for the fiscal year ending Dec 2026, a step up from the -40.9% reported in FY2025.

Sources:Cash Flow Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterJun 2026
$95M+4.3% QoQ
Last fiscal yearDec 2025
$247.1M-40.9% YoY
LTMJun 2026
$375.3M+59.0% YoY
Net Income past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+322.2%+25.9%-296.3 pp
1 year-40.9%+98.1%+139.0 pp
3-year CAGR+277.3%+36.9%-240.4 pp
5-year CAGR+29.1%—
10-year CAGR——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

Net Income history

USD · from the cash flow

Latest · FY2025
247.1M USD
Year-over-year change
-40.9%
4-year CAGR
+95.8%
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

Net Income vs competitors

How PODD compares with its peers on the latest reported figures

  • PODD's LTM Jun 2026 net income of $375.3M is the 2nd largest of the 5 companies compared; the peer median is $76.81M.
  • Its year-over-year change of +59.0% is the 2nd highest of 5, against a peer median of +5.7%.
  • Net income amounts to 12.3% of revenue for PODD, versus a peer median of 40.2%.
PODD Competitors Peer median
Net Income for PODD and competitors
Company Period LTM YoY 3-year CAGR% of revenue
DXCMDexCom, Inc.LTM Jun 2026$999.7M +74.9%+34.8%20.1%
PODDInsulet CorporationLTM Jun 2026$375.3M +59.0%+277.3%12.3%
TNDMTandem Diabetes Care, Inc.LTM Mar 2026$94.55M -48.6%+29.3%9.2%
SENSSenseonics Holdings, Inc.LTM Mar 2026$87.19M +17.8%—214.2%
BBNXBeta Bionics, Inc.LTM Mar 2026$66.44M -6.4%+4.2%60.3%
Peer median (excluding PODD) $76.81M+5.7%+29.3%40.2%

Competitors are the stored peer set for PODD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income16.8M4.6M206.3M418.3M247.1M
Depreciation & Amortization57.4M63.2M72.8M80.8M90.4M
Deferred Income Tax0(1M)500K(136.9M)62.2M
Stock-Based Compensation34.4M40.9M48.3M69.3M62.7M
Change in Working Capital(263.6M)(2.5M)(190.6M)(17M)(23.1M)
Accounts Receivables(71.3M)(51.8M)(154.2M)(10.4M)(140.2M)
Inventory(154.4M)(49.1M)(53.6M)(32.4M)(10.6M)
Accounts Payables(15.6M)(2.4M)(11M)2.2M49.2M
Other Working Capital(22.3M)100.8M28.2M23.6M78.5M
Other Non-Cash Items86.9M13.8M8.4M15.8M130M
Operating Cash Flow(68.1M)119M145.7M430.3M569.3M
Capital Expenditures(122.7M)(157.3M)(75.6M)(124.9M)(191.6M)
Acquisitions (Net)0(26M)(3M)00
Purchases of Investments0(7.8M)(7.2M)(12.2M)0
Sales of Investments40M0000
Other Investing Activities0000(31.1M)
Investing Cash Flow(82.7M)(191.1M)(119.4M)(146.2M)(222.7M)
Debt Repayment49.4M(39.8M)(27M)(40.6M)(708.1M)
Common Stock Issued23.5M16.3M26.9M20.1M33.9M
Common Stock Repurchased0000(59.6M)
Dividends Paid00000
Other Financing Activities(32.2M)(16.8M)(13.5M)(7.6M)138.5M
Financing Cash Flow40.7M(40.3M)(13.6M)(28.1M)(595.3M)
Effect of Forex Changes(5.5M)(4.3M)1.8M(6.8M)11.5M
Net Change in Cash(115.6M)(116.7M)14.5M249.2M(237.3M)
Free Cash Flow(190.8M)(38.3M)70.1M305.4M377.7M

Insulet Corporation

NASDAQ:PODD

Intrinsic Alpha fair value

Locked

Current Price

$139.98

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.